HOME >> BIOLOGY >> NEWS
International symposium on radar altimetry in Venice, 13 to 18 March 2006

The life of Venetians is strictly connected to the sea-level, which is one of the reasons why Venice was chosen to host the international symposium "15 Years of Progress in Radar Altimetry" a major scientific event on a class of space-borne sensor that precisely records the height of the global sea surface along with that of freshwater bodies, land surfaces and the icy cryosphere.

Organised by the European Space Agency (ESA) together with the French Space Agency (CNES), the '15 Years of Progress in Radar Altimetry' symposium is being held in Venice Lido from 13 to 18 March 2006.

The symposium takes place a few weeks after ESA received the green light from its Member States to build and launch a CryoSat recovery mission, Cryosat-2, which is expected to be launched in March 2009.

Thanks to its main instrument, the Synthetic Aperture Interferometric Radar Altimeter (SIRAL), CryoSat-2 will precisely monitor changes in the elevation and thickness of polar ice sheets and floating sea ice. These data will help explain the connection between the melting of the polar ice and the rise in sea levels and how this is contributing to climate change.

Radar altimeters were first flown in space in the 1970s, aboard NASA's Skylab, Geos 3 and Seasat. Initially these sensors were dedicated to the study of oceans, but as the technology improved so did their reach. The European experience in radar altimetry dates back to 1991, when ESA launched its ERS-1 satellite, which included the first Radar Altimeter (RA), precisely calibrated over the water of Venice. Since then, ESA has continued to accumulate homogeneous data by follow-up instruments aboard ERS-2 and Envisat satellites.

In 1992, as a support to the World Ocean Circulation Experiment program, NASA and CNES launched the Topex/Poseidon mission, fully optimised to measure the sea surface topography with an unprecedented accuracy of a few centimetres.

The Topex/Poseidon mission was
'"/>

Contact: Simonetta Cheli
simonetta.cheli@esa.int
39-069-418-0350
European Space Agency
7-Mar-2006


Page: 1 2 3

Related biology news :

1. National Ecological Observatory Network featured at ESA/SER Joint International Conference
2. International team to honor 30th anniversary of deep-sea vent discovery in Galpagos
3. 2nd International EuroFIR Congress
4. Clinical trial data regarding NKTR-061 will be presented at ATS International Conference
5. Smithsonian hosts Polar Science Symposium to celebrate International Polar Year 2007-2008
6. Eduardo Slatopolsky honored with 2007 ISN Amgen International Prize
7. 4th International Conference on Ethical Issues in Biomedical Engineering
8. International risk research strategy and funding needed for nanotech safety
9. Pezcoller Foundation-AACR International Award for Cancer Research recognizes Mina J. Bissell
10. International Astronautical Federation joins project to protect World Heritage sites
11. International Society for Heart and Lung Transplantation 27th Annual Meeting and Scientific Sessions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: International symposium radar altimetry Venice March

(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... 2015  Analyst Report Issued by Small Cap IR. In 2011, ... planet-wide, transactions at merchants on the leading payment cards rose ... credit, debit, and prepaid cards reached 6.54 billion.  Eight million ... card usage in 2012, and credit and debit card fraud ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
(Date:2/27/2015)... and SUMMERLAND, British Columbia , ... XON ), a leader in synthetic biology, ... acquire  Okanagan Specialty Fruits (OSF), the pioneering agricultural ... the world,s first non-browning apple. Through the acquisition, Intrexon ... that is more appetizing and convenient for consumers while ...
(Date:2/27/2015)... Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... studies for its newly developed Bruton,s tyrosine kinase ... been completed. The results of these preclinical evaluations ... Drug Administration. The feedback received from the Agency ... first-in-human study. Additional preclinical work is required to ...
(Date:2/27/2015)... A paper published today, " Financing ... in Science Translational Medicine, demonstrates the ... the risk associated with investing in the treatment ... of funding for developing so-called "orphan" drugs. ... between scientists at the National Center for Advancing ...
(Date:2/27/2015)... , Feb. 27, 2015 Research and Markets ... "Global Market Report of Trypsin" report to their offering. ... 9002-07-7) aims at providing comprehensive data on Trypsin globally and ... , North America , Latin ... close attention to Trypsin This report focuses on ...
Breaking Biology Technology:Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Global Market Report of Trypsin 2014-2018 2
Cached News: